Reaction

Tenosynovitis Stenosans reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 552 reports · 47 co-occurring drugs

As of the last recalculation, Tenosynovitis Stenosans appears in 552 FAERS reports alongside 47 co-occurring drug terms. The strongest observed disproportionality signal is METHYLPREDNISOLONE ACETATE (PRR 434.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Methylprednisolone Acetate	79	434.0	438.3
Trimethoprim	49	171.9	172.6
Amitriptyline Hydrochloride	50	118.1	118.4
Tofacitinib Citrate	38	117.3	117.6
Esomeprazole Magnesium Capsule, Delayed Release	38	106.0	106.2
Esomeprazole Magnesium Delayed Release Capsules	38	106.0	106.2
Esomeprazole Magnesium Dihydrate	38	105.5	105.8
Naproxen Sodium Tablet, Coated	25	72.9	73.0
Naproxen Sodium, Coated Tablets	25	72.9	73.0
Sulfasalazine	119	72.8	72.9
Naproxen Sodium 220Mg	25	72.8	72.9
Meloxicam	77	57.9	58.0
Drs. Clotrimazole	17	57.2	57.3
Family Wellness Clotrimazole	17	57.2	57.3
Clotrimazole Topical	17	57.2	57.2
Alendronate Sodium	118	55.8	55.9
Desloratadine	15	54.2	54.3
Clotrimazole	17	53.8	53.9
Naproxen	90	51.4	51.5
Adalimumab-Fkjp	52	46.6	46.7
Adalimumab-Aaty	52	45.6	45.7
Adalimumab-Adaz	57	45.3	45.4
Dexlansoprazole	46	45.3	45.3
Azathioprine	88	44.6	44.7
Esomeprazole	63	43.1	43.2
Hydroxychloroquine Sulfate	80	38.6	38.6
Ketoconazole	17	38.2	38.2
Oxycodone And Acetaminophen Tablets	11	35.5	35.5
Naproxen Sodium	102	32.8	32.8
Golimumab	61	30.0	30.0
Leflunomide	72	29.7	29.7
Diclofenac Potassium, Film Coated	6	27.2	27.2
Diclofenac Potassium Tablets	6	27.2	27.2
Ranitidine Hydrochloride	33	24.3	24.3
Tocilizumab	63	23.4	23.4
Tofacitinib	93	22.7	22.7
Certolizumab Pegol	61	21.9	22.0
Cortisone Acetate	7	21.6	21.7
Diclofenac Potassium	6	21.2	21.2
Linagliptin	10	21.0	21.0
Pseudoephedrine Hcl	6	20.7	20.8
Abatacept	65	19.9	19.9
Oxycodone And Acetaminophen	12	19.8	19.8
Ranitidine	87	19.4	19.4
Pseudoephedrine Hydrochloride	5	18.5	18.5
Desvenlafaxine Succinate	11	15.7	15.7
Cannabidiol	9	14.7	14.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.